Search

everythinglearnresearchcommunity

for

Search:↓

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

Stress hormone CRF causes hair loss and stops hair cell growth.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

The poem ends by asking for case reports on serious health issues like Telogen Effluvium.

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Telogen Effluvium is a condition where more hair than usual falls out after stress or fever.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Triphasic Progressive is more effective against hair loss.

Telogen effluvium is hair loss caused by disruption of the normal hair cycle.

Oral minoxidil may slow male pattern baldness and cause body hair growth, but hair loss can happen after stopping it.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

If a dog's skin tests are normal but it has hair loss, consider other non-endocrine causes and choose tests based on the hair loss pattern.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Oral contraceptives may cause hair loss in women.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

A woman's temporary hair loss was caused by high prolactin levels from her medication.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.

Short Anagen Syndrome causes persistently short hair and increased shedding, usually improving after puberty.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

"Dread shed" is common with minoxidil but less so with other hair loss treatments.

Hair growth and shedding involve specific cell changes and gene roles.

The belief about hair shedding phases is likely incorrect and needs reevaluation.